Join to view full profile
1206 Pleasant St Dept GeneralDes Moines, IA 50309
Phone+1 515-241-8363
Fax+1 319-356-8682
Dr. Alexander is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
New York Presbyterian Hospital (Columbia Campus)Fellowship, Pediatric Surgery, 2021
University of Iowa Health Care Medical CenterResidency, Surgery, 2019 - 2020
University of Missouri-Columbia School of MedicineClass of 2014
Certifications & Licensure
IA State Medical License 2014 - 2027
American Board of Surgery Surgery- American Board of Surgery Pediatric Surgery
Publications & Presentations
PubMed
- 1 citationsEnhanced recovery after surgery improves clinical outcomes in adolescent bariatric surgery.Nicholas Schmoke, Christopher Nemeh, Tania Gennell, Dana Schapiro, Alexander V Chalphin
Surgery for Obesity and Related Diseases. 2024-09-01 - 2 citationsThoracoscopic Excision of Mediastinal Bronchogenic Cysts in Children: A Case Series.Nicholas Schmoke, Chloe Porigow, Yeu Sanz Wu, Matthew Alexander, Alexander V Chalphin
Journal of Laparoendoscopic & Advanced Surgical Techniques. Part A. 2024-07-01 - 28 citationsPharmacological ascorbate inhibits pancreatic cancer metastases via a peroxide-mediated mechanism.Brianne R. O'Leary, Matthew S. Alexander, Juan Du, Devon L. Moose, Michael D. Henry
Scientific Reports. 2020-10-19
Journal Articles
- Pharmacological Ascorbate Reduces Radiation-Induced Normal Tissue Toxicity and Enhances Tumor Radiosensitization in Pancreatic CancerSamuel R Schroeder, Matthew S Alexander, Joseph J Cullen, Daniel J Berg, Bryan G Allen, John M Buatti, Clinical Cancer Research
Grant Support
- Molecular and therapeutic correction of XMEA using novel zebrafish and mouse modelsUNIVERSITY OF ALABAMA AT BIRMINGHAM2026–2027
- Molecular and therapeutic correction of XMEA using novel zebrafish and mouse modelsUNIVERSITY OF ALABAMA AT BIRMINGHAM2026–2027
- Dystrophin as a novel regulator of the circadian clock in skeletal muscle and the brainUNIVERSITY OF ALABAMA AT BIRMINGHAM2024–2026
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: